Crosstalk between miRNAs and DNA Methylation in Cancer
M Saviana, P Le, L Micalo, D Del Valle-Morales… - Genes, 2023 - mdpi.com
miRNAs are some of the most well-characterized regulators of gene expression. Integral to
several physiological processes, their aberrant expression often drives the pathogenesis of …
several physiological processes, their aberrant expression often drives the pathogenesis of …
The diagnostic and prognostic value of miR-155 in cancers: an updated meta-analysis
Y Wu, Q Hong, F Lu, Z Zhang, J Li, Z Nie… - Molecular Diagnosis & …, 2023 - Springer
Background MicroRNA-155 has been discussed as a biomarker in cancer diagnosis and
prognosis. Although relevant studies have been published, the role of microRNA-155 …
prognosis. Although relevant studies have been published, the role of microRNA-155 …
[HTML][HTML] Advances in quantifying circulatory microRNA for early disease detection
Highlights•Liquid biopsy-based early disease detection assays are key enablers of
preventive healthcare.•Circulatory miRNAs are promising liquid biopsy biomarkers that are …
preventive healthcare.•Circulatory miRNAs are promising liquid biopsy biomarkers that are …
Potential utility of miRNAs for liquid biopsy in breast cancer
X Liu, D Papukashvili, Z Wang, Y Liu, X Chen… - Frontiers in …, 2022 - frontiersin.org
Breast cancer (BC) remains the most prevalent malignancy due to its incidence rate,
recurrence, and metastasis in women. Conventional strategies of cancer detection …
recurrence, and metastasis in women. Conventional strategies of cancer detection …
Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis
NPG Nascimento, TB Gally, GF Borges, LCG Campos… - BMC cancer, 2022 - Springer
Background Cervical cancer is a preventable disease, but it is a major public health problem
despite having a good prognosis when diagnosed early. Although the Pap smear has led to …
despite having a good prognosis when diagnosed early. Although the Pap smear has led to …
MicroRNA-4516 in urinary exosomes as a biomarker of premature ovarian insufficiency
Premature ovarian insufficiency (POI) is a typical disorder of amenorrhea that lasts for a
minimum of four months in women< 40 years old and is typically characterized by reduced …
minimum of four months in women< 40 years old and is typically characterized by reduced …
miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer
Y Li, J Xun, B Wang, Y Ma, L Zhang, L Yang… - Journal of Translational …, 2021 - Springer
Background Colorectal cancer is one of the most common malignancy in the world. It has
been reported that cancer stem cells (CSCs) serve as the primary drivers of tumorigenesis …
been reported that cancer stem cells (CSCs) serve as the primary drivers of tumorigenesis …
Phthalate promotes atherosclerosis through interacting with long-non coding RNA and induces macrophage foam cell formation and vascular smooth muscle damage
C Liu, Q Qin, J Xu, X Li, H Cong - Chemosphere, 2022 - Elsevier
Background Phthalates are commonly used in variety of plastic products. Previously it has
been revealed that di (2-ethylhexyl) phthalate (DEHP), as the most common member of the …
been revealed that di (2-ethylhexyl) phthalate (DEHP), as the most common member of the …
miRNA in molecular diagnostics
MicroRNAs are a class of small non-coding RNA molecules that regulate gene expression
on post-transcriptional level. Their biogenesis consists of a complex series of sequential …
on post-transcriptional level. Their biogenesis consists of a complex series of sequential …
Multiomic Approaches for Cancer Biomarker Discovery in Liquid Biopsies: Advances and Challenges
PM Diaz, A Leehans, P Ravishankar… - Biomarker …, 2023 - journals.sagepub.com
Cancer is a complex and heterogeneous disease that poses a significant threat to global
health. Early diagnosis and treatment are critical for improving patient outcomes, and the …
health. Early diagnosis and treatment are critical for improving patient outcomes, and the …